Sangamo Therapeutics has higher earnings, but lower revenue than Novavax. Novavax is trading at a lower price-to-earnings ratio than Sangamo Therapeutics, indicating that it is currently the more ...

Apple has begun the mass production of its M5 chip, which is set to power next-generation products, including the upcoming Mac series and iPad. Coinciding with long-standing reports, the Cupertino ...

BMW hasn’t confirmed the release date for the refreshed 5-Series, i5, and M5, but expect 2027. These renderings show the sedan with lights inspired by the BMW Vision Driving Experience.

Apple has begun mass production of its next-generation M5 chip, according to South Korean media, with the processor expected to arrive in devices potentially as soon as this year. ET News reports ...

That model — complete with Apple’s upcoming M5 chip — is an intriguing prospect. Will Apple offer a total revamp, or will it be a more modest upgrade? What can we expect from the M5 chip?

Apple has yet to officially announce the MacBook Pro M5. However, given that the company typically releases new MacBook Pro models in October, we could see successors to the MacBook Pro 14-inch M4 ...

Two lanes of the M5 were closed in Devon this afternoon, Friday, February 21. There were long delays forming on the motorway southbound between Tiverton and Cullompton due to a broken down vehicle.

At the end of 2024, we heard reports that Apple’s 2025 release schedule includes an M5-based iPad Pro and MacBook Pro. According to a new report, it looks like those products are right on schedule.

Now Gilead is spending a further $150 million upfront to access the cutting edge gene-editing technology of another Californian biotech, Sangamo. The ambition for this cancer-focused collaboration ...

In 2024, the iPad Pro was the first device to debut Apple’s brand-new M4 chipset. It would be a full five months before the company’s MacBook laptops would catch up, suggesting that Apple was ...

Pfizer and Sangamo are hoping for a faster trajectory with their experimental treatment. The partners' one-shot giroctocogene fitelparvovec therapy has cleared a phase 3 trial, showing it was ...

This includes both CPU and GPU. But a new report suggests that the M5 Pro chip may take a different approach of having more separated CPU and GPU in order to improve performance and boost ...